FBI Director Kash Patel quietly visited Beijing last week to discuss fentanyl and law enforcement cooperation, two people familiar with the trip told Reuters, marking a rare direct engagement between the U.S. and China on one of the most contentious issues in their relationship. The visit came days after U.S. President Donald Trump and Chinese President Xi Jinping declared “consensus” on tackling the deadly synthetic opioid that has fueled a worsening drug crisis in the United States.
According to one person briefed on the trip, Patel arrived in the Chinese capital on Friday and held discussions with senior Chinese security officials the following day before returning to Washington. Neither Washington nor Beijing officially confirmed the visit, which Reuters reported for the first time. China’s Ministry of Public Security, Ministry of Foreign Affairs, and the U.S. embassy in Beijing did not immediately respond to Reuters requests for comment.
The clandestine trip follows a modest easing of trade tensions after Trump agreed to halve tariffs on Chinese goods from 20% to 10% as part of a broader understanding on fentanyl control reached during last month’s presidential talks. Trump told reporters that Xi had pledged to “work very hard to stop the flow” of fentanyl into the United States, where the substance remains the leading cause of overdose deaths.
Treasury Secretary Scott Bessent confirmed that the new consensus would be managed through a bilateral working group, though it remains unclear whether Patel’s meetings addressed the framework directly. The move marks a shift from earlier Trump administration policies that relied heavily on sanctions and punitive measures, demanding proof of enforcement before easing economic pressure on China.
Chinese officials, for their part, have long defended their record on fentanyl regulation, arguing that Beijing has already enacted sweeping measures to control precursor chemicals and accusing Washington of using the issue as a form of political “blackmail.” Despite such friction, the Xi-Trump understanding also touched other trade-sensitive areas, including the resumption of U.S. soybean purchases by China and Beijing’s agreement to pause newly announced export restrictions on rare earth elements critical to global technology supply chains.
Patel’s discreet mission underscores the fragile nature of this renewed cooperation. While both nations stand to benefit from curbing the fentanyl epidemic and stabilizing trade relations, the absence of public acknowledgment of Patel’s visit reflects the deep mistrust that continues to define U.S.-China ties. Whether this latest diplomatic overture will translate into sustained action remains uncertain, but as Reuters notes, it may signal the first cautious step toward a thaw in one of the world’s most consequential rivalries.
